Volume 27, Issue 3 pp. 238-243

Dilated Cardiomyopathy in Epidermolysis Bullosa: A Retrospective, Multicenter Study

Irene Lara-Corrales M.D., M.Sc.

Irene Lara-Corrales M.D., M.Sc.

Hospital for Sick Children Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Jemima E. Mellerio M.D.

Jemima E. Mellerio M.D.

Great Ormond Street Hospital for Children NHS Trust, London, UK

Search for more papers by this author
Anna E. Martinez M.D.

Anna E. Martinez M.D.

Great Ormond Street Hospital for Children NHS Trust, London, UK

Search for more papers by this author
Adrian Green B.Sc.

Adrian Green B.Sc.

Great Ormond Street Hospital for Children NHS Trust, London, UK

Search for more papers by this author
Anne W. Lucky M.D.

Anne W. Lucky M.D.

Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio

Search for more papers by this author
Richard G. Azizkhan M.D.

Richard G. Azizkhan M.D.

Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio

Search for more papers by this author
Dedee F. Murrell M.D.

Dedee F. Murrell M.D.

St. George Hospital Sydney, Sydney, North South Wales

University of NSW, Sydney, Sydney, North South Wales, Australia

Search for more papers by this author
Anna L. Agero M.D.

Anna L. Agero M.D.

St. George Hospital Sydney, Sydney, North South Wales

Search for more papers by this author
Paul F. Kantor M.D.

Paul F. Kantor M.D.

Hospital for Sick Children Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Elena Pope M.D.

Elena Pope M.D.

Hospital for Sick Children Toronto, Toronto, Ontario, Canada

Search for more papers by this author
First published: 25 May 2010
Citations: 34
Address correspondence to Elena Pope, Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G1H4, Canada, or e-mail: [email protected].

Research conducted at: Hospital for Sick Children, Toronto, ON, Canada.

Abstract

Abstract: Dilated cardiomyopathy (DC) has been reported in severe epidermolysis bullosa (EB) subtypes. Poor nutritional status, low carnitine levels, selenium deficiency, chronic iron overload, drugs and viral etiology have been proposed as potential contributors. This was a retrospective, descriptive, multicenter study describing EB patients that developed DC, and determining potential pre-disposing risk factors. Fifteen patients were enrolled in the study; 11 of them were male subjects (73%). Eighty-seven per cent of the participants had dystrophic EB and 13% had junctional EB. Mean age at diagnosis of DC was 12.18 ± 4.99 years. Chronic anemia was diagnosed in 13 of 15 patients (86.7%). Sixty per cent of patients had prior red blood cell transfusions. At diagnosis, selenium levels were low in 55% of the patients (n = 11) and total carnitine levels were low in 45% of the patients (n = 11). Systolic function was moderately impaired, with a mean shortening fraction of 19.38% (SD = 5.04, n = 8). After a mean follow-up period of 6.3 ± 4.8 years, six patients were alive without being on any medications (40.0%), two were alive on medications (13.3%) and seven had died (46.7%). Limitations of the study was that it was a retrospective chart review with relatively small sample size. Retrospective chart review, relatively small sample size. This study substantiates the association between DC and EB. Currently, there is no single risk factor identified in EB patients that leads to DC. Further prospective studies are needed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.